Hypertonicity-induced cation channels

Acta Physiol (Oxf). 2006 May-Jun;187(1-2):21-5. doi: 10.1111/j.1748-1716.2006.01561.x.

Abstract

Whenever studied in a quantitative fashion, hypertonicity-induced cation channels (HICCs) are found to be the main mediators of regulatory volume increase. In most instances, these channels are either inhibited by amiloride (but insensitive to Gd3+ and flufenamate) or they are efficiently blocked by Gd3+ and flufenamate (but insensitive to amiloride). Of note, however, from two preparations so far a mixed type of pharmacology has also been reported. Whereas the ion selectivity of amiloride-sensitive HICCs has not been studied in much detail yet, amiloride-insensitive channels are either equally permeable to Na+, K+, Cs+ and Li+ but impermeable to N-methyl-D-glucamine (NMDG+) or they exhibit a permeability to Li+ and NMDG+ that amounts to some 50% when compared with that of Na+. Also in this respect, however, some peculiarities do exist. Concerning the actual molecular correlate, evidence was reported that HICCs may be related to the (amiloride-sensitive) epithelial Na+ channel and/or to transient receptor potential channels. Recent findings suggest that HICCs may contribute to cell proliferation, just as the K+ channels that are employed in regulatory volume decrease are mediators of the opposing process, i.e. apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Amiloride / pharmacology*
  • Animals
  • Cations
  • Cell Membrane / drug effects
  • Cell Membrane Permeability
  • Cell Size
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism*
  • Humans
  • Hypertonic Solutions / metabolism
  • Osmolar Concentration
  • Potassium Channels / metabolism
  • Sodium Channel Blockers / pharmacology*

Substances

  • Cations
  • Hypertonic Solutions
  • Potassium Channels
  • Sodium Channel Blockers
  • Amiloride